Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of EsoDuo in Patients With Non-erosive Reflux Disease (NERD)
NCT03928470Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esomeprazole + sodium bicarbonate in non-erosive reflux disease (NERD) (2 arms), sponsored by Chong Kun Dang Holdings. Primary endpoint: Complete resolution of heartburn (HB), Last 7 days of treatment at 4 weeks. Started Jan 2019; status: completed.
02
Drugs
esomeprazole + sodium bicarbonate
03
Conditions
non-erosive reflux disease (NERD)
Beyond the preview
Go deeper on NCT03928470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03928470.